전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 2Status Recruiting
CGTLimited DatastaleShanghai Xiniao Biotech Co., Lt…Phase 1

UCAR T-cell group (UCAR T-cell group)

Systemic Lupus Erythematosus · Myasthenia Gravis

#MyastheniaGravis#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleAvenCell Europe GmbHPhase 1

IMP (UniCAR02-T, UniCAR02-T (IMP))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Discontinued
AntibodyLimited DatastaleXencor, Inc.Phase 2

XmAb18087 (XmAb18087)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#monoclonal-antibody#SmallCellLungCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleXencor, Inc.Phase 1

XmAb541 (XmAb541)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase1#monoclonal-antibody#Xencor
Trials 2Status Recruiting
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, YL201 and atezolizumab)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#monoclonal-antibody#Roche
Trials 2Status Recruiting
AntibodyLimited DatastaleGenmabPhase 2

Zalutumumab (Zalutumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Genmab
Trials 2Status Active
AntibodyLimited DatastaleAmgenPhase 1

acapatamab (acapatamab)

Metastatic Castration-resistant Prostate Cancer; Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#Antibody#Phase1#monoclonal-antibody#ProstateCancer+1
Trials 2Status Discontinued
CGTLimited DatastaleKite, A Gilead CompanyPhase 1

anti-CD19 CAR-T (anti-CD19 CAR-T)

B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

anti-CD19 IL10/IL15 CAR-NK (anti-CD19 IL10/IL15 CAR-NK)

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleCity of Hope Medical CenterPhase 1

autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells)

Adult Grade III Lymphomatoid Granulomatosis; Cutaneous B-cell Non-Hodgkin Lymphoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
AntibodyLimited DatastaleNeovii BiotechPhase 2

ertumaxomab (ertumaxomab)

Metastatic Breast Cancer; Advanced Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedBreastCancer+1
Trials 2Status Discontinued
CGTLimited DatastaleIIT MediTech (Jiangsu) Co. LtdPhase 2

fhB7H3.CAR-Ts (fhB7H3.CAR-Ts)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
AntibodyLimited DatastalePETHEMA FoundationPhase 2

ibritumomab tiuxetan (ibritumomab tiuxetan)

Lymphoma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#Lymphoma+1
Trials 2Status Discontinued
CGTLimited DatastaleUniQure Biopharma B.V.Phase 2

intra-striatal rAAV5-miHTT (intra-striatal rAAV5-miHTT)

Huntington's Disease · Huntington Disease

#HuntingtonDisease#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 2

mCapOX plus Cetuximab (mCapOX plus Cetuximab)

Colo-rectal Cancer; Capecitabine · Colorectal Cancer (CRC)

#ColorectalCancerCRC#Antibody#Phase2#monoclonal-antibody#Colo-rectalCancer+2
Trials 2Status Active
CGTLimited DatastaleCG Oncology, Inc.Phase 2

oncolytic adenovirus expressing GMCSF (oncolytic adenovirus expressing GMCSF)

Bladder Cancer; High Grade · Bladder Cancer

#BladderCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Discontinued
CGTLimited DatastaleBeacon TherapeuticsPhase 2

rAAV1-CB-hAAT (rAAV1-CB-hAAT)

Alpha-1 Antitrypsin Deficiency · Alpha 1-Antitrypsin Deficiency

#Alpha1-AntitrypsinDeficiency#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Active
AntibodyLimited DatastaleRadboud University Medical Cent…Preclinical

111Indium-bevacizumab (111Indium-bevacizumab)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#Antibody#Preclinical#monoclonal-antibody#Radboud
Trials 1Status Active
AntibodyLimited DatastaleColumbia UniversityPhase 1

131I-apamistmab (131I-apamistmab)

Sickling Disorder Due to Hemoglobin S · Sickling Disorder Due to Hemoglobin S

#SicklingDisorderDuetoHemoglobinS#Antibody#Phase1#monoclonal-antibody#Columbia
Trials 1Status Recruiting

36 / 103 pages

← PreviousNext →